Why the study?
Does oxprenolol improve pregnancy outcomes compared to methyldopa in pregnant women with moderately severe hypertension?
Population
53 pregnant women with moderately severe hypertension
Comparison
Oxprenolol vs Methyldopa
Design
RCT, randomly allocated
Follow-up
through neonatal period
Authors
Loading...
Supports preferring oxprenolol to methyldopa for hypertension in pregnancy; extends RCT evidence on beta-blocker choice for maternal-fetal outcomes.
Does oxprenolol improve pregnancy outcomes compared to methyldopa in pregnant women with moderately severe hypertension?
Oxprenolol appears safe and effective for controlling moderately severe hypertension in pregnancy, potentially offering advantages over methyldopa for fetal growth and wellbeing.
Gallery et al. (1979) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: